COST-EFFECTIVENESS OF RADON MITIGATION IN CANADA

被引:0
|
作者
LETOURNEAU, EG
KREWSKI, D
ZIELINSKI, JM
MCGREGOR, RG
机构
关键词
D O I
暂无
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This paper examines the cost effectiveness of comprehensive strategies for reducing exposure to radon gas in indoor air in Canadian homes. The analysis is conducted within the context of a general framework for risk management programme evaluation which includes well-known evaluation techniques such as cost effectiveness and cost-benefit analyses as special cases. Based on this analysis, it is clear that any comprehensive programme to reduce exposure to environmental radon will be extremely expensive, and may not be justifiable in terms of health impact, particularly when considered in relation to other public health programmes. None the less, testing of homes at the point of sale and installing sub-slab suction equipment to reduce exposure to indoor radon where necessary appears to be a relatively cost-effective radon mitigation strategy. Because of regional differences in radon levels in Canada, radon mitigation will be more cost effective in some areas than others. In general, radon mitigation was found to be most cost effective in cities with relatively high levels of radon.
引用
收藏
页码:593 / 598
页数:6
相关论文
共 50 条
  • [31] Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study
    Drolet, Melanie
    Zhou, Zhou
    Sauvageau, Chantal
    DeWals, Philippe
    Gilca, Vladimir
    Amini, Rachid
    Benard, Elodie
    Brisson, Marc
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (34) : E932 - E939
  • [32] Estimation of the Health Impact and Cost-Effectiveness of Influenza Vaccination with Enhanced Effectiveness in Canada
    Fisman, David N.
    Tuite, Ashleigh R.
    PLOS ONE, 2011, 6 (11):
  • [33] Cost-effectiveness of lamivudine for the treatment of chronic hepatitis B in Canada
    Haiderali, AM
    Villa, K
    Schrammel, P
    HEPATOLOGY, 1999, 30 (04) : 347A - 347A
  • [34] Cost-effectiveness of asenapine in the treatment of schizophrenia and bipolar disorder in Canada
    Lachaine, J.
    Beauchemin, C.
    Mathurin, K.
    Gilbert, D.
    Beillat, M.
    Corson, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 122 - 122
  • [35] EVALUATION OF THE COST-EFFECTIVENESS OF ELECTRICAL ENERGY CONSERVATION IN CANADA.
    Anon
    Research and Development Report - Canadian Electrical Association, 1982, (28 U 206):
  • [36] Cost-effectiveness of tPA therapy in acute ischemic stroke in Canada
    Oh, PI
    Nadareishvili, ZG
    Korman, S
    Tran, C
    Norris, JW
    STROKE, 1999, 30 (01) : 267 - 267
  • [37] The cost-effectiveness of bevacizumab for the treatment of advanced ovarian cancer in Canada
    Duong, M.
    Wright, E.
    Yin, L.
    Martin-Nunez, I.
    Ghatage, P.
    Fung-Kee-Fung, M.
    CURRENT ONCOLOGY, 2016, 23 (05) : E461 - E467
  • [38] COST-EFFECTIVENESS OF FARICIMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA IN CANADA
    Buhrer, C.
    Paulo, T.
    Diles, D.
    VALUE IN HEALTH, 2022, 25 (12) : S140 - S140
  • [39] The cost-effectiveness of infliximab (Remicade®) in the treatment of ankylosing spondylitis in Canada
    Kobelt, G
    Andlin-Sobocki, P
    Maksymowych, WP
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (04) : 732 - 740
  • [40] Cost-effectiveness of lumiracoxib compared to celecoxib for the treatment of osteoarthritis in Canada
    Sambrook, J. C.
    Levy, A. R.
    Osenenko, K.
    Kindundu, C.
    Barbeau, M.
    VALUE IN HEALTH, 2007, 10 (03) : A117 - A118